Company Filing History:
Years Active: 2025
Title: Seung-Tae Kang: Innovator in GLP-1 Receptor Agonists
Introduction
Seung-Tae Kang is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1 receptor agonists. His work is crucial in addressing diseases associated with GLP-1 activity.
Latest Patents
Seung-Tae Kang holds a patent for a GLP-1 receptor agonist. The invention relates to a compound represented by Formula 1, wherein A, B, L, X, and R are defined as described in the patent. This compound, or a pharmaceutically acceptable salt thereof, serves as a GLP-1 receptor agonist and may be useful in the prevention or treatment of diseases associated with GLP-1 activity. He has 1 patent to his name.
Career Highlights
Seung-Tae Kang is currently employed at Hyundai Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential impact on therapeutic strategies.
Collaborations
Some of his notable coworkers include Han Kyu Lee and Jeong-Un Hwang, who contribute to the collaborative efforts in research and development at Hyundai Pharm Co., Ltd.
Conclusion
Seung-Tae Kang is a key figure in the development of GLP-1 receptor agonists, with a focus on innovative solutions for health challenges. His contributions to the field are invaluable and continue to shape the future of pharmaceutical research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.